The study found that the price tag for the second-generation Bruton tyrosine kinase inhibitor would need to be reduced by 30% ...

Rectal discharge may appear in the toilet after pooping or on toilet paper without the urge to have a bowel movement. This ...

In the years since targeted treatments for CLL were introduced, their use in the second line has increased, but chemotherapy ...

During a Case-Based Roundtable® event, Andrew H. Lipsky, MD, moderated a discussion on the efficacy and safety of newer BTK ...

A 64-year-old man experienced severe visual distortions, resembling a Picasso painting, and various distressing symptoms for ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

The introduction of biologic agents, especially rituximab (RTX), a chimeric monoclonal antibody targeting CD20+ B cells, has revolutionized the treatment landscape. This review synthesized the current ...

Treatment options for PPMS are limited and often fail to slow disability progression. Both Ocrevus and rituximab are designed to promote the death of B-cells, the immune cells that produce the ...

Here’s our process. If you’re managing a sexually transmitted infection (STI), you have options for treatment. While you can visit a healthcare professional in person for an evaluation and ...

Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...

Researchers found that the most common first-line treatment regimen was fludarabine, cyclophosphamide, and rituximab. The use of targeted therapies for chronic lymphocytic leukemia (CLL ...